A Study to Assess Disease Activity in Adolescent and Adult Participants With Atopic Dermatitis Who Receive Oral Upadacitinib Tablets in a Real-World Setting
Clinical trial NCT05139836 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05139836
- Sponsor
- AbbVie
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2021-12-13
- Primary completion
- 2027-09-01
- Enrollment
- 634
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.